VETERINARY DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Global Veterinary Diagnostics Market Size and Forecast – 2025 to 2032

The Global Veterinary Diagnostics Market is estimated to be valued at USD 8.81 Bn in 2025 and is expected to reach USD 16.84 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2025 to 2032. This significant growth is driven by increasing awareness about animal nutrition & health, rising pet ownership, and advancements in diagnostic technologies. The expanding livestock industry and rising demand for rapid and accurate diagnostic solutions further contribute to the market’s robust expansion during this period.

Key Takeaways of the Global Veterinary Diagnostics Market

• In the global veterinary diagnostics market, instruments—including analyzers and imaging systems—are expected to account for the largest share by product and service, capturing 51. 1% in 2025.
• By animal type, companion animals such as dogs, cats, horses, and other household pets lead the market with an estimated 55. 2% share.
• Within the technology segment, immunodiagnostics segment is expected to hold the highest share of 23. 4% in 2025, attributed to its broad applicability, high sensitivity, and effectiveness across various disease categories.
• North America is expected to lead the market with a share of 38. 3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 23.4% in 2025.

Market Overview

A key trend shaping the veterinary diagnostics market is the integration of innovative technologies such as molecular diagnostics, point-of-care testing, and AI-powered analytics. Additionally, the growing emphasis on preventive healthcare for both companion and farm animals is fueling the demand for early diagnostic tools. Moreover, increasing government initiatives and investments to control zoonotic diseases are enhancing market adoption, reinforcing steady growth and innovation in veterinary diagnostic solutions.

For instance, in April 2025, India initiated a pioneering inter-ministerial scientific study to address zoonotic spillover risks at the human-wildlife-environment interface. Led by the Indian Council of Medical Research (ICMR), a premier biomedical research agency, the study aims to develop a real-time surveillance model for detecting zoonotic diseases in bird sanctuary workers and nearby residents.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Veterinary Diagnostics Market Insights, By Product and Service – Instruments Dominate as Advanced Instrumentation Drives Precision in Veterinary Diagnostics

In terms of product and service, instruments such as analyzers and imaging systems hold the highest market share within the global veterinary diagnostics space with an estimated share of 51.1% in 2025. This dominant position can be attributed primarily to the increasing demand for high-precision, rapid, and comprehensive diagnostic capabilities in veterinary care. Instruments like biochemical analyzers and hematology analyzers provide essential laboratory data that aid veterinary professionals in accurately diagnosing a wide spectrum of animal diseases, from infectious conditions to metabolic disorders. Moreover, diagnostic imaging systems—including ultrasound, X-ray, MRI, and CT scanners—have revolutionized the detection and monitoring of internal abnormalities in animals, facilitating non-invasive and detailed examinations that were previously challenging.

The growing emphasis on preventive health management in both companion and livestock animals accentuates the need for sophisticated instrumental diagnostics. Early detection offered by these instruments helps reduce morbidity and mortality rates, which is particularly crucial in production animals where disease outbreaks can lead to significant economic losses. In companion animal care, pet owners are increasingly willing to invest in advanced diagnostics to ensure timely and effective treatment.

For instance, in June 2023, Boule Diagnostics, a Sweden-based global provider of hematology systems, launched the H50V, a new 5-part veterinary hematology analyzer for the European market. Designed for cost-effective diagnostics, the H50V offers rapid results in one minute, supports 13 predefined animal profiles, and features over 30 parameters. With a compact design, touchscreen interface, and built-in mixer, it caters to a wide range of veterinary clinics and labs.

Veterinary Diagnostics Market Insights, By Animal Type - Companion Animals Fuel the Demand for Specialized Diagnostics

Among animal types, the companion animals segment, including dogs, cats, horses, and other household pets, holds the highest market share in veterinary diagnostics with an estimated share of 55.2% in 2025. This prominence stems from the growing humanization of pets and the increasing awareness about animal health as a critical aspect of overall well-being among pet owners. As pets transition from merely being animals to integral family members, there is heightened demand for quality veterinary care akin to human healthcare. This shift drives greater utilization of diagnostic testing to detect diseases early, manage chronic conditions, and personalize treatment regimens.

Pet owners’ willingness to spend on comprehensive veterinary services, including diagnostic procedures, has led to expanded offerings by veterinary clinics, both urban and suburban. This is backed by the rise in preventive health check-ups and wellness programs tailored specifically for companion animals, which require regular diagnostic monitoring. Moreover, the increase in pet adoption and population growth in urban centers further fuels this trend. Diseases common in companion animals—such as diabetes, renal failure, and cardiac disorders—necessitate sophisticated and routine diagnostics, pushing market demand upward.

Veterinary Diagnostics Market Insights, By Technology - Immunodiagnostics are at the Forefront of Technological Innovation owing to their Widespread Applications in Animal Healthcare

Within the technology segment of the veterinary diagnostics market, immunodiagnostics secures the highest share with an estimated 23.4% in 2025, driven by its versatility, sensitivity, and widespread application across disease categories. Immunodiagnostic tests leverage antigen-antibody interactions to detect pathogens, markers of infection, or immune status indicators, making them invaluable tools for diagnosing infectious diseases, autoimmune disorders, and certain cancers in animals. Their rapid turnaround time and relatively straightforward operation facilitate their use in both laboratory and field settings.

A significant factor propelling immunodiagnostics is the increasing prevalence of zoonotic and emerging infectious diseases, which require accurate and timely detection to prevent outbreaks in both animals and humans. Immunodiagnostic platforms—including enzyme-linked immunosorbent assay (ELISA) and lateral flow assays—offer reliable and cost-effective options for screening large animal populations, particularly in livestock environments, where disease control is critical to food safety and economic stability. These technologies also support vaccination efficacy monitoring and herd health assessments, making them indispensable tools for veterinary epidemiologists.

Regional Insights

To learn more about this report, Download Free Sample

North America Veterinary Diagnostics Market Analysis and Trends

North America’s dominance in the global veterinary diagnostics market with an estimated share of 38.3% in 2025 is driven by a well-established healthcare infrastructure combined with advanced veterinary research capabilities. The region benefits from strong government support, including stringent animal health regulations and proactive funding for livestock disease control, which boosts demand for cutting-edge diagnostic tools.

The presence of leading biotechnology and diagnostics companies such as IDEXX Laboratories, Zoetis, and Heska Corporation has solidified North America's position, as these firms continuously innovate with rapid diagnostic kits and integrated diagnostic solutions. Additionally, North America’s extensive pet ownership culture fuels demand for companion animal diagnostics, while a robust livestock farming ecosystem necessitates regular monitoring and disease management, further strengthening the market’s foundation.

Asia Pacific Veterinary Diagnostics Market Analysis and Trends

The Asia Pacific region is expected to exhibit the fastest growth in the veterinary diagnostics market with a share of 23.4% in 2025, primarily driven by the rapid expansion of livestock farming, increasing pet adoption, and rising awareness about animal health. Government initiatives in countries like China and India to enhance animal disease surveillance and strengthen food safety standards play a pivotal role in accelerating market development. The expanding veterinary diagnostics industry ecosystem includes notable players such as BioNote (South Korea), Mindray (China), and Elanco’s operations in Southeast Asia, which focus on providing affordable and accessible diagnostic solutions tailored to local needs.

In November 2024, the West Bengal Livestock Development Corporation (WBLDC), a state-run entity based in Salt Lake, launched a diagnostic service for pets like dogs and cats through its unit, the Centre for Laboratory Animal Research and Training (CLART) in West Bengal, India. In partnership with pet care company, Onpets, the service offers home collection of blood and stool samples, which can be booked online via the government lab’s website.

Veterinary Diagnostics Market Outlook for Key Countries

U.S. Veterinary Diagnostics Market Trends

The U.S. veterinary diagnostics market is shaped by a mature veterinary healthcare system underscored by widespread pet ownership and integration of advanced technology such as molecular diagnostics and point-of-care devices. Companies like IDEXX Laboratories lead this market by offering comprehensive diagnostic panels and data management solutions to veterinarians. Government agencies such as the United States Department of Agriculture, (USDA) enforce animal health regulations supporting diagnostic adoption in livestock. The country’s focus on companion animal diagnostics and zoonotic disease monitoring continues to drive innovation and adoption across diagnostic modalities.

In January 2024, Center Point Bio-Tech (CPB), a U.S.-based veterinary diagnostics innovator, launched AlphaION, a modular and AI-powered diagnostic system, at the 2024 Veterinary Meeting and Expo in Orlando. Designed for in-clinic use, AlphaION integrates five component machines to perform a wide range of blood, fecal, urine, and bacterial tests. It is the first veterinary system to utilize surface acoustic wave (SAW) technology for biomarker detection and to automate bacterial culture and sensitivity testing in hospitals—enhancing test accuracy, reducing turnaround time, and improving antibiotic stewardship.

U.K. Veterinary Diagnostics Market Trends

The U.K. veterinary diagnostics market is witnessing a shift toward advanced, preventive care solutions driven by rising pet ownership, increased awareness of zoonotic diseases, and technological innovation. Demand for rapid, point-of-care testing is growing, especially in small and mid-sized clinics seeking efficient and affordable diagnostic tools. Additionally, regulatory scrutiny—such as the ongoing CMA investigation into veterinary service pricing—is influencing investment decisions and market dynamics. There's also a notable rise in digital diagnostics integration, with AI-powered tools and telemedicine platforms enhancing clinical decision-making and diagnostic accuracy across the country.

In July 2024, EKF Diagnostics, a U.K.-based manufacturer of medical and veterinary diagnostic devices, unveiled the Biosen C-Line, a benchtop glucose and lactate analyzer. Designed for high usability, it features a touchscreen interface and advanced connectivity via EKF Link, allowing integration with lab IT systems. It supports accurate monitoring in both clinical and performance settings.

China Veterinary Diagnostics Market Trends

China’s rapid urbanization and growing demand for high-quality animal protein fuel the expansion of the veterinary diagnostics market. Increasing government emphasis on animal disease control, coupled with investments in veterinary infrastructure, supports higher diagnostic adoption rates. Key players such as Mindray and BGI Genomics provide innovative diagnostic tools ranging from molecular to serological assays, tailored to meet the demands of both livestock and companion animals. Policy frameworks encouraging animal welfare and food safety further propel the market, while partnerships with global entities help transfer technology and advance diagnostic capabilities.

In August 2023, Chengdu Seamaty Technology Co., Ltd., a China-based manufacturer of point-of-care diagnostic devices, unveiled four new veterinary analyzers tailored for pet hospitals and clinics. Among them, the VG2 Vet Blood Gas Electrolyte Immunoassay Analyzer stands out for combining fluorescence immunoassay with blood gas and electrolyte testing in a compact, portable format.

India Veterinary Diagnostics Market Trends

The veterinary diagnostics market in India is experiencing significant growth, fueled by the increasing adoption of advanced PCR-based technologies for early disease detection in both livestock and companion animals. This growth is further supported by proactive government initiatives and a rising demand for enhanced animal healthcare across the country.

Notably, under the "Make in India" initiative, the Indian Council of Agricultural Research (ICAR) and the Indian Veterinary Research Institute (IVRI) have developed diagnostic tools such as the Bluetongue Sandwich ELISA (sELISA) and Japanese Encephalitis IgM ELISA kits for use in animals including sheep, goats, cattle, buffalo, and camels. Additionally, in 2023, the Central Institute for Research on Buffaloes introduced the Preg-D kit, a urine-based early pregnancy diagnostic test, further strengthening diagnostic capabilities in the sector.

End User Feedback and Unmet Needs – Global Veterinary Diagnostics Market

• End users across veterinary clinics, diagnostic laboratories, academic institutions, and government veterinary departments have expressed varied feedback regarding the use of veterinary diagnostic solutions. A widely cited positive experience comes from veterinary laboratories utilizing automated immunodiagnostic analyzers for early detection of zoonotic diseases in companion animals. These systems have been praised for their high sensitivity, faster turnaround time, and minimal manual intervention, which enhances diagnostic efficiency and supports rapid clinical decision-making. Additionally, multi-animal compatibility and integration with lab management systems have improved workflow for larger facilities, particularly in urban veterinary practices.
• However, several challenges persist across emerging economies and rural settings. A common concern raised by end-users—especially independent veterinary clinics and public sector animal health programs—is the high cost of diagnostic instruments and reagents, limiting their accessibility. Furthermore, the lack of portable or point-of-care diagnostic solutions hinders field-level disease detection in livestock and poultry farms. Technological gaps also remain in terms of species-specific test development and real-time integration with centralized health databases. Addressing these unmet needs through cost-effective, customizable, and scalable diagnostic platforms could unlock new growth avenues, enhance disease surveillance, and foster innovation. Policymakers and manufacturers can drive market expansion by offering subsidized models, investing in R&D for rural deployment, and providing robust post-sales training and technical support.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In June 2025, bioMérieux, a global leader in in vitro diagnostics based in France, launched VETFIRE, a next-generation PCR-based diagnostic kit designed for rapid detection of equine infectious respiratory diseases. The ready-to-use kit delivers highly accurate results in under 20 minutes, enabling simultaneous identification of seven respiratory pathogens using a simple nasopharyngeal swab.
• In June 2025, Enalees, a biotech company specializing in veterinary molecular diagnostics, launched Rhéa, a new range of rapid molecular tests for ruminants such as cattle, sheep, and goats. Designed for field use by rural veterinarians, Rhéa enables on-site diagnosis in under 40 minutes without lab support. The first panel, Rhéa Vector-Borne Diseases, detects four key pathogens—Theileria spp., Babesia spp., Anaplasma spp., and Borrelia spp.—offering both multiplex and monovalent formats.
• In April 2024, Antech Diagnostics, a leading North America veterinary diagnostics company under Mars Science and Diagnostics, launched two major innovations—AIS RapidRead and the Nu.Q Canine Cancer Test. AIS RapidRead, powered by AI and trained on the world’s largest library of companion animal images, provides near-instant radiology insights to enhance diagnostic speed and accuracy. Meanwhile, the Nu.Q Canine Cancer Test offers a rapid and targeted screening solution for high-risk and older dogs, detecting common cancers like lymphoma and hemangiosarcoma with over 75% accuracy, enabling early diagnosis and improved treatment outcomes.
• In December 2024, Zoetis Inc., the world’s leading animal health company, announced the global launch of Vetscan OptiCell, an AI-powered, cartridge-based hematology analyzer set to debut at VMX 2025 in Orlando. Designed for point-of-care use, it combines viscoelastic focusing (VEF) and artificial intelligence to deliver fast, accurate complete blood count (CBC) results in minutes. The system offers space, time, and cost savings for clinics, featuring a screenless, single-use cartridge with integrated reagents and waste management—eliminating calibration, reducing maintenance, and preventing contamination.

Top Strategies Followed by Global Veterinary Diagnostics Market Players

• Established players dominate the sector through significant investments in research and development, aiming to innovate and launch high-performance diagnostic products that meet evolving veterinary needs. These companies prioritize the development of advanced technologies such as molecular diagnostics, immunoassays, and point-of-care testing devices, enabling faster and more accurate disease detection in animals. Strategic partnerships with major industry players and original equipment manufacturers (OEMs) form a core part of their approach, helping them integrate complementary expertise and technology solutions while strengthening their supply chains.
  • In February 2024, MiDOG Animal Diagnostics, a U.S.-based veterinary diagnostics company specializing in microbial detection, launched its advanced All-in-One Diagnostic Test. This innovative solution enables rapid detection of bacterial and fungal infections, including antibiotic resistance, across a wide range of animal species. Designed to replace conventional testing methods, the molecular-based test supports more efficient and comprehensive treatment strategies for pets, livestock, and exotic animals alike.

• Mid-level companies in the veterinary diagnostics market position themselves by offering cost-effective yet reliable diagnostic solutions tailored to price-sensitive consumers such as smaller veterinary clinics and local animal farms. These firms focus on balancing quality and affordability, often introducing product lines that provide essential diagnostic capabilities without the premium pricing of advanced technologies featured by larger competitors. To augment their technological capacity and production volume, mid-sized players frequently engage in collaborations with technology providers, contract manufacturers, and distribution partners.
  • In January 2025, IDEXX Laboratories, Inc., a global leader in veterinary diagnostics and pet healthcare innovation, introduced affordable IDEXX Cancer Dx, a breakthrough blood test for early detection of lymphoma in dogs. Designed to integrate into routine wellness panels, the test offers results in 2–3 days and is available for as low as USD 15. This aligns with strategies of mid-level veterinary diagnostics firms that focus on cost-effective, accurate solutions tailored for small clinics and local farms, enabling broader access to preventive care.

• Small-scale market entrants in the global veterinary diagnostics space are increasingly gaining traction by focusing on niche segments and specialized diagnostic applications. These companies leverage emerging technologies such as artificial intelligence, microfluidics, and portable diagnostic platforms to address specific animal health challenges that are often overlooked by larger players. By targeting localized markets or specific species, they offer tailored solutions that align with regional disease profiles and unique veterinary requirements, allowing them to compete effectively despite constrained resources.
  • In February 2024, MiDOG Animal Diagnostics, a U.S.-based veterinary diagnostics innovator, introduced an All-in-One Molecular Diagnostic Test. This test swiftly detects bacterial and fungal infections, including antibiotic resistance, across multiple animal species. It aims to replace conventional methods with rapid, accurate diagnostics for personalized veterinary treatment.

Market Report Scope

Veterinary Diagnostics Market Dynamics

To learn more about this report, Download Free Sample

Veterinary Diagnostics Market Driver - Increasing Prevalence of Animal Diseases

The rising incidence of infectious and chronic diseases among both livestock and companion animals is significantly propelling the demand for advanced veterinary diagnostic solutions worldwide. Factors such as intensive farming practices, changing climatic conditions, and increased interaction between wildlife and domesticated animals contribute to the spread of diseases, making early and accurate diagnosis critical for effective disease management. Moreover, zoonotic diseases, which can transfer from animals to humans, have heightened awareness about the importance of monitoring animal health closely. This growing concern has led veterinarians and animal health professionals to increasingly rely on sophisticated diagnostic tools to detect pathogens, monitor health status, and implement timely interventions. Additionally, the expanding adoption of rapid and point-of-care diagnostic kits facilitates on-site testing, reducing the time lag in treatment decisions.

For instance, in May 2025, the World Organisation for Animal Health (WOAH), a global authority on animal health, published its inaugural State of the World’s Animal Health report. The report highlights a sharp rise in infectious animal diseases worldwide, raising concerns for livestock, wildlife, and human health. Notably, avian influenza outbreaks in mammals doubled in a year, while diseases like Peste des Petits Ruminants (PPR) and African Swine Fever (ASF) are spreading across new borders.

Veterinary Diagnostics Market Opportunity - Expansion of Point-of-Care and In-House Testing

The global veterinary diagnostics market is witnessing significant growth opportunities through the expansion of point-of-care diagnostic and in-house testing solutions. Rising demand for rapid, accurate, and on-site diagnostic capabilities is driving veterinary practitioners, livestock producers, and pet owners to adopt portable and user-friendly diagnostic tools that enable immediate decision-making. This shift is fueled by the need to reduce turnaround time associated with traditional laboratory testing, which often delays treatment and management processes.

Advancements in technology have led to the development of compact, easy-to-operate devices capable of performing multiple tests onsite—ranging from blood analysis and infectious disease detection to biomarker identification. Additionally, increasing awareness regarding animal health, rising incidences of zoonotic diseases, and the growing pet population are pushing veterinary clinics and farms to invest in in-house diagnostic equipment to enhance operational efficiency and improve clinical outcomes.

In October 2023, Fluxergy, a U.S.-based diagnostics company specializing in multiplex, multimodal point-of-care (POC) laboratory testing, has launched a new rapid PCR assay for detecting Streptococcus equi ss equi in equine nasal swab samples. The assay identifies the SeM/eqbE gene and delivers results within 60 minutes, offering a cost-effective, in-house solution for veterinary labs.

Analyst Opinion (Expert Opinion)

• The global veterinary diagnostics market is experiencing steady growth, driven by rising pet ownership, increasing awareness about zoonotic diseases, and continued advancements in diagnostic technologies such as molecular testing, PCR, and immunodiagnostics. Regulatory support from animal health authorities and global organizations like the World Organisation for Animal Health (OIE) is driving diagnostic adoption in the livestock sector. Growing demand for preventive healthcare and early disease detection in companion and livestock animals is opening new opportunities for point-of-care testing and mobile diagnostic units. However, challenges remain in terms of affordability, limited access to advanced diagnostics in rural areas, and a shortage of skilled veterinary professionals.
• Events such as the World Veterinary Association Congress (WVAC), International Conference on Veterinary Science and Medicine, and the Animal Health Innovation Asia Summit have played a critical role in fostering collaboration between industry stakeholders, regulators, and researchers. These platforms have spotlighted innovative technologies, promoted cross-border veterinary health policies, and encouraged public-private partnerships. For instance, IDEXX Laboratories’ deployment of next-generation diagnostic platforms in Asia and Zoetis’ collaboration with African governments to support livestock diagnostics have strengthened local animal health frameworks. Pilot initiatives like India’s “One Health” programme and the EU’s VetCAb-S project are further shaping the market by integrating human-animal-environment health surveillance, creating a strong pipeline for innovation and investment in veterinary diagnostics.

Market Segmentation

•  Product And Service Insights (Revenue, USD Bn, 2020 - 2032)
  • Instruments (Analyzers, Imaging Systems)
  • Consumables and Reagents (Test Kits, Panels, Slides, Stains, Media)
  • Software and Services (Diagnostic Imaging Software, Laboratory Information Management Systems, Testing Services)
•  Animal Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others (e.g., rabbits, birds)
  • Livestock Animals
    • Cattle
    • Pigs
    • Poultry
    • Sheep and Goats
    • Others (e.g., camels, buffalo)
•  Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Immunodiagnostics
    • ELISA
    • Lateral Flow Assays
    • Immunoassay Analyzers
  • Molecular Diagnostics
    • PCR
    • Microarrays
    • Nucleic Acid Sequencing
  • Clinical Biochemistry
    • Enzymology
    • Electrophoresis
    • Blood Chemistry Analysis
    • Others (Microbiology, Parasitology Tests, Pathology)
  • Diagnostic Imaging
    • X-ray Systems
    • Ultrasound Systems
    • MRI Systems
    • CT Scanners
    • Endoscopy Systems
•  Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Infectious Diseases (Viral, Bacterial, Parasitic, Fungal)
  • Non-infectious Diseases (Endocrine, Oncology, Cardiology, Orthopedic, etc.)
  • Hereditary/Congenital Disorders
  • General Wellness and Preventive Care
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Veterinary Hospitals and Clinics
  • Veterinary Reference Laboratories
  • Point-of-Care Testing Centers
  • Livestock Farms and Animal Breeders
  • Others (Academic and Research Institutions)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • IDEXX Laboratories Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Heska Corporation
  • Bio-Rad Laboratories Inc.
  • Neogen Corporation
  • Virbac SA
  • Randox Laboratories Ltd.
  • Biomerieux SA
  • IDvet
  • Fujifilm Corporation
  • Bionote Inc.
  • BioChek BV
  • Agrolabo SpA
  • Eurolyser Diagnostica GmbH

Sources

Primary Research Interviews

• Industry Stakeholders List
  • Veterinary Diagnostic Equipment Manufacturers
  • Veterinary Laboratory Service Providers
• End-users List
  • Veterinarians at Animal Hospitals and Clinics
  • Livestock Farm Managers

Government and International Databases

• U.S. Food and Drug Administration (FDA) – Center for Veterinary Medicine
• European Medicines Agency (EMA) – Veterinary Medicines
• World Organisation for Animal Health (WOAH/OIE)
• World Health Organization (WHO) – One Health Initiative
• National Institute of Animal Health (Japan)
• Canadian Food Inspection Agency (CFIA)
• Centers for Disease Control and Prevention (CDC) – Zoonotic Diseases

Trade Publications

• Veterinary Practice News
• The Veterinary Record
• Clinician's Brief
• Today's Veterinary Business

Academic Journals

• Journal of Veterinary Diagnostic Investigation
• Preventive Veterinary Medicine
• Veterinary Microbiology
• BMC Veterinary Research
• Journal of Veterinary Internal Medicine

Reputable Newspapers

• The New York Times – Health & Science
• The Guardian – Animal Health & Environment
• BBC News – Science & Health
• The Washington Post – Health

Industry Associations

• American Veterinary Medical Association (AVMA)
• British Veterinary Association (BVA)
• World Veterinary Association (WVA)
• Federation of Veterinarians of Europe (FVE)
• Indian Veterinary Association (IVA)
• International Federation for Animal Health (IFAH)

Public Domain Resources

• ScienceDirect (Open Access Articles)
• ResearchGate (Veterinary Studies)
• OpenGrey – System for Information on Grey Literature in Europe

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years